Table: Kobayashi Pharmaceutical - 9-MTH group results
Oct 30 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2019 Sep 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 117.79 115.77 173.00
(+1.7 pct) (+7.5 pct) (+3.3 pct)
Operating 20.30 19.57 27.30
(+3.7 pct) (+14.1 pct) (+3.8 pct)
Recurring 21.45 20.59 27.90
(+4.2 pct) (+21.2 pct) (+1.9 pct)
Net 15.25 13.77 19.00
(+10.7 pct) (+17.3 pct) (+5.4 pct)
EPS 194.20 yen 174.23 yen 240.29 yen
EPS Diluted 174.13 yen
Ann Div 66.00 yen 68.00 yen
-Q2 div 33.00 yen 31.00 yen
-Q4 div 35.00 yen 35.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows